Enrique Seco-Meseguer

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

A. Borobia, H. Schuitemaker, Andrew Gibson, 2022, The Lancet Infectious Diseases.

Melatonin in the Prophylaxis of SARS-CoV-2 Infection in Healthcare Workers (MeCOVID): A Randomised Clinical Trial

A. Borobia, A. Carcas, J. Arribas, 2022, Journal of clinical medicine.

Advancing pharmacogenetic testing in a tertiary hospital: a retrospective analysis after 10 years of activity

Arturo Gómez López De Las Huertas, S. Stewart, Jose Manuel Dodero-Anillo, 2023, Frontiers in pharmacology.